In traditional clinical medicine, we often think in thresholds: a patient is either hypertensive or they aren't; a blood sugar level is either "normal" or "diabetic." However, a vast body of recent epidemiological research suggests that for many of the most critical drivers of human health—from air pollution and systemic inflammation to dietary antioxidants—there is no such thing as a "safe" threshold or a "saturation" point for benefit.
Instead, these factors follow a linear dose-response relationship. This means that every incremental change in exposure or behavior, no matter where a person starts on the spectrum, results in a proportional change in health risk or survival.
The Myth of the Safe Threshold
The most striking finding across these studies is the absence of a "floor" for risk factors. For decades, public health guidelines have sought to identify "safe" levels of exposure. Yet, research into urban environments and lifestyle toxins suggests these thresholds may be illusory.
In a study of emergency department visits in Shanghai, Juan Xie and Wei-ying Zhu found that concentration-response curves for pollutants like $NO_2$ and $PM_{10}$ are strictly linear. There was no identifiable "safe" level of air pollution; even small increases in smog correlated with a rise in acute coronary events Acute Effects of Outdoor Air Pollution on Emergency Department Visits Due to Five Clinical Subtypes of Coronary Heart Diseases in Shanghai, China.
This "no safe limit" pattern extends to behavioral toxins. While moderate drinking was once thought to be harmless or even protective, recent meta-analyses highlight that for conditions like breast cancer and hypertension, the risk profile is linear. Every additional gram of alcohol consumed increases the risk, challenging the notion of a universally safe lower limit. Similarly, Min Mu demonstrated that the risk of pulmonary heart disease increases steadily with the total duration and intensity of silica exposure, with no evidence of a plateau Occupational exposure to silica and risk of heart disease: a systematic review with meta-analysis.
Incremental Gains in Protective Factors
The inverse is also true: protective factors often provide continuous, incremental benefits rather than reaching a point of diminishing returns. This suggests that "optimal" health is a moving target that can always be improved.
- Nutrition: Kanran Wang and colleagues found that whole grain consumption and lung cancer risk follow a linear dose-response pattern; more is simply better Association of whole grain food consumption with lung cancer risk: a prospective cohort study. This is mirrored in the work of Jun Liu on carotenoids, where higher serum concentrations were linked to a stepwise reduction in metabolic syndrome Higher serum carotenoid concentrations associated with a lower prevalence of the metabolic syndrome in middle-aged and elderly Chinese adults.
- Exercise and Lifestyle: Stefanie Lerche used machine learning to show that physical exercise provides a proportional protective effect on aging trajectories without a clear saturation point Machine learning-based personalized composite score dissects risk and protective factors for cognitive and motor function in older participants.
- Cardiovascular Metrics: Yan Liu and Hongjie Chi observed that for every additional "Life’s Simple 7" metric a person meets, their risk of mortality drops further, suggesting that even partial adherence to health guidelines offers a survival advantage The Ideal Cardiovascular Health Metrics Associated Inversely with Mortality from All Causes and from Cardiovascular Diseases among Adults in a Northern Chinese Industrial City.
Why Linearity Works: The Biological Intuition
Why would biological systems respond so linearly? One compelling explanation comes from the "cellular target" hypothesis. Haley Grant and Yifan Zhang proposed that the linear link between obesity and cancer exists because larger organs simply contain more cells. If every cell has a baseline probability of mutating, a 10% increase in organ volume (and thus cell count) leads to a roughly 10% increase in the "targets" for cancer Organ size increases with obesity and correlates with cancer risk.
A similar logic applies to systemic inflammation. Markers like the Neutrophil-to-Lymphocyte Ratio (NLR) or the Systemic Immune-Inflammation Index (SII) act as a proxy for the "inflammatory load" on the body. Justin D. Salciccioli and Chen Zhao have shown that mortality risk rises linearly with these ratios. There is no "safe" amount of chronic inflammation; every incremental increase in the ratio represents a steady erosion of physiological resilience The neutrophil-lymphocyte ratio predicts all-cause and cardiovascular mortality among United States adults with COPD.
From Binary Diagnosis to Continuous Risk
The shift toward linear models has profound implications for how we screen and treat patients. If risk is continuous, then the "normal" range on a blood test may still harbor significant, modifiable risk.
For example, Mengying Xu and Jingmin Zhou found that the ratio of inflammatory markers to heart mass (sST2/LVMI) predicts heart failure mortality on a continuous scale Increased Ratio of sST2/LVMI Predicted Cardiovascular Mortality and Heart Failure Rehospitalization in Heart Failure with Reduced Ejection Fraction Patients. Similarly, Gailing Liu demonstrated that every 10-unit increase in a metabolic insulin resistance score corresponds to a precise, linear decrease in kidney filtration capacity Association between the metabolic score for insulin resistance (METS-IR) and estimated glomerular filtration rate (eGFR).
By treating these metrics as continuous scales rather than binary thresholds, clinicians can identify high-risk individuals much earlier and recognize that even small improvements—a slightly better diet, a few more minutes of exercise, or a marginal reduction in inflammatory markers—provide a quantifiable and meaningful benefit to long-term survival.